Cited by 1,010Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 142 of the 146 references it cites were found in a registry or an index.

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

Wild, Robert A., Carmina, Enrico, Diamanti-Kandarakis, Evanthia, Dokras, Anuja, Escobar-Morreale, Hector F., Futterweit, Walter, Lobo, Rogerio, Norman, Robert J., Talbott, Evelyn, Dumesic, Daniel A.·2010·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jc.2009-2724

Open this paper in CoChat — free account

Abstract

OBJECTIVE: Women with polycystic ovary syndrome (PCOS) often have cardiovascular disease (CVD) risk factors. The Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society created a panel to provide evidence-based reviews of studies assessing PCOS-CVD risk relationships and to develop guidelines for preventing CVD. PARTICIPANTS: An expert panel in PCOS and CVD reviewed literature and presented recommendations. EVIDENCE: Only studies comparing PCOS with control patients were included. All electronic databases were searched; reviews included individual studies/databases, systematic reviews, abstracts, and expert data. Articles were excluded if other hyperandrogenic disorders were not excluded, PCOS diagnosis was unclear, controls were not described, or methodology precluded evaluation. Inclusion/exclusion criteria were confirmed by at least two reviewers and arbitrated by a third. CONSENSUS PROCESS: Systematic reviews of CVD risk factors were compiled and submitted for approval to the AE-PCOS Society Board. CONCLUSIONS: Women with PCOS with obesity, cigarette smoking, dyslipidemia, hypertension, impaired glucose tolerance, and subclinical vascular disease are at risk, whereas those with metabolic syndrome and/or type 2 diabetes mellitus are at high risk for CVD. Body mass index, waist circumference, serum lipid/glucose, and blood pressure determinations are recommended for all women with PCOS, as is oral glucose tolerance testing in those with obesity, advanced age, personal history of gestational diabetes, or family history of type 2 diabetes mellitus. Mood disorder assessment is suggested in all PCOS patients. Lifestyle management is recommended for primary CVD prevention, targeting low-density and non-high-density lipoprotein cholesterol and adding insulin-sensitizing and other drugs if dyslipidemia or other risk factors persist.

Integrity signals

Registry

Crossref · 10.1210/jc.2009-2724

Cites

142 of 142 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Withdrawn: Postmenopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival: Results from the National Institutes of Health—National Heart, Lung, and Blood Institute Sponsored Women’s Ischemia Syndrome Evaluation
Shaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0425 · Cited by 427
Retracted
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“In two large intervention studies, almost 60% relative risk reduction in conversion to diabetes mellitus occurred in obese individuals (BMI, 30 kg/ m(2)) with IGT randomized to intensive lifestyle modification to reduce body weight by 5–7% (101, 102); less dramatic improvement occurred in less obese individuals (BMI,…”
Background
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Bariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457

Show all 146 references

Research works printed but not linked: 1

Zawadki, 1992, Diagnostic criteria for polycystic ovary syndrome: towards a rational approach, In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications;, 377

Sorted by citations

Items 801–900 of 1,000

Polycystic Ovarian Syndrome : Its Impact on Periodontal Disease
Sherene, A. (2020) · Indian Journal of Forensic Medicine & Toxicology · doi:10.37506/ijfmt.v14i4.11710 · Cited by 1
Hyperandrogenism: Acne and Hirsutism
Evans, M. B., & Hill, M. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-17002-2_40-1 · Cited by 1
Cardiometabolic consequences of PCOS
Podgórska, K., Puła, A., Krzysiek, U., Artykiewicz, K., Gorczyca, K., Kozieł, P., Grodkiewicz, M., Słupczyńska, A., Urbaś, W., & Czarkowski, M. (2022) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.13.01.021 · Cited by 1
Risk Factors for Ischemic Heart Disease in Women
Shen, B., Maeda, U., Eisenberg, S., & Merz, C. N. B. (2022) · Springer eBooks · doi:10.1007/978-0-387-85960-6_7 · Cited by 2
Polycystic Ovary Syndrome (PCOS): Clinical Features, Risk Factors, Biomarkers, Treatment, and Therapeutic Strategies
Fatima, Q., Jeelani, H., Abass, S., Farooq, M., & Rashid, F. (2023) · Springer eBooks · doi:10.1007/978-981-99-2193-5_9 · Cited by 2
A study on the factors affecting polycystic ovary syndrome in young women
Küçükakça, A. Ş., & GÜRBÜZ, T. (2023) · Journal of Controversies in Obstetrics & Gynecology and Pediatrics · doi:10.51271/jcogp-0021 · Cited by 1
A Complete Overview of the Polycystic Ovarian Syndrome with Recent Advancement in Clinical Trial
Mukherjee, S., Rai, D., Ghoshal, D., Chakraborty, T., & Karati, D. (2024) · Current Women s Health Reviews · doi:10.2174/0115734048268656231127064615 · Cited by 1
Polycystic Ovarian Syndrome: Current Insights
Naidu, S. J. K., Ramdin, S., Naicker, T., Moodley, J., Naidoo, G., & Govender, N. (2024) · Biomedical visualization · doi:10.1007/978-3-031-68501-9_8 · Cited by 1
Cardiometabolic trajectories across midlife in parous women with polycystic ovary syndrome
Chen, Y., Salmon, K., Rifas‐Shiman, S. L., Fitz, V. W., Kazemi, M., Shifren, J. L., Hivert, M., Oken, E., Chavarro, J. E., & Perng, W. (2025) · American Journal of Epidemiology · doi:10.1093/aje/kwaf078 · Cited by 1
The Polycystic Ovary Syndrome Status - A Risk Factor for Future Cardiovascular Disease
Ilie, I. R. P., Ilie, R., MOCAN, L. C., Georgescu, C. E., Duncea, I., Mocan, T., Ghibu, S., & Iancu, C. (2012) · InTech eBooks · doi:10.5772/32072 · Cited by 1
Синдром поликистозных яичников. Официальное заявление Европейского общества эндокринологии
Conway, G. S., Dewailly, D., & Diamanti‐Kandarakis, E. (2015) · The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy · doi:10.18370/2309-4117.2015.25.32-52 · Cited by 1
Self-citation
Dificuldades e armadilhas no diagnóstico da síndrome dos ovários policísticos Difficulties and pitfalls in the diagnosis of polycystic ovary syndrome
Antônio, J., Marcondes, M., Roberto, C., Barcellos, G., & Rocha, M. P. (2011) · Cited by 1
Update on Polycystic Ovary Syndrome
Carron, R. (2016) · Journal of the Dermatology Nurses’ Association · doi:10.1097/jdn.0000000000000259 · Cited by 1
Síndrome de ovario poliquístico: fenotipos y enfermedad cardiovascular
Gámez, J. M. C., Abruzzese, G. A., Cerrone, G. E., Lioy, G., Mormandi, E. A., Otero, P., Belli, S., Levalle, O. A., Graffigna, M. N., & Motta, A. B. (2016) · Revista Argentina de Endocrinología y Metabolismo · doi:10.1016/j.raem.2016.11.004 · Cited by 2
Metabolic Aspects of Polycystic Ovary Syndrome
Dhesi, A. S., & Morelli, S. S. (2015) · Postgraduate Obstetrics & Gynecology · doi:10.1097/01.pgo.0000471433.43201.11 · Cited by 1
No 350-Hirsutisme : évaluation et traitement
Liu, K. E., Motan, T., & Claman, P. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.08.012 · Cited by 1
FATORES DE RISCO PARA O DESENVOLVIMENTO DE DOENÇAS CARDIOVASCULARES EM MULHERES COM SÍNDROME DOS OVÁRIOS POLICÍSTICOS
Nunes, R. D., Walber, F. K., & Traebert, J. L. (2018) · Arquivos Catarinenses de Medicina · doi:10.63845/csbbrj54 · Cited by 1
Die adipöse Patientin mit Kinderwunsch
Keck, C., & Sonntag, B. (2019) · Der Gynäkologe · doi:10.1007/s00129-019-4467-x · Cited by 1
Eficacia de la acupuntura Tung para las hormonas sexuales en el síndrome del ovario poliquístico: ensayo controlado aleatorio
Cao, Y., Chen, H., Zhao, D., Zhang, L., Yu, X., Zhou, X., & Liu, Z. (2019) · Revista Internacional de Acupuntura · doi:10.1016/j.acu.2019.04.006 · Cited by 1
Medical interventions to improve outcomes in infertile obese women planning for pregnancy
Talaulikar, V. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817919-2.00016-4 · Cited by 1
A PROSPECTIVE OBSERVATIONAL STUDY ON EVALUATION OF COMPLICATIONS IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
Vidhya, M., Bindhu, C., mounika, G. S., & Harika, K. (2020) · International Research Journal of Pharmacy · doi:10.7897/2230-8407.110768
Polycystic ovary syndrome
Lobo, R. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-65399-2.00048-6 · Cited by 1
Self-citation
IVF efficiency in different phenotypes of polycystic ovary syndrome
Nikolayenkov, I. P., Kazymova, O. E., Sudakov, D. S., & Dymarskaya, Y. R. (2021) · Journal of obstetrics and women s diseases · doi:10.17816/jowd61933 · Cited by 1
Impact of Polycystic Ovary Syndrome, Metabolic Syndrome, Obesity, and Follicular Growth Arrest in Women Health
Villarroel, C., Henríquez, S., Kohen, P., & Devoto, L. (2021) · ISGE series · doi:10.1007/978-3-030-63650-0_7 · Cited by 1
Cardiometabolic risk in women with PCOS
Carmina, E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00016-x · Cited by 1
Self-citation
Comparative effect of Aerobic Training versus Plyometric Training among Young Obese Women with Poly Cystic Ovarian Syndrome
Paul, J., Syeda Khanam, P., Jain, P., & Abinaya., T. (2021) · International Journal of Medical and Exercise Science · doi:10.36678/ijmaes.2021.v07i04.003
Hyperandrogenism: Acne and Hirsutism
Evans, M. B., & Hill, M. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-14881-1_40 · Cited by 1
Síndrome de ovario poliquístico, el riesgo cardiovascular olvidado
Corredor-Rengifo, D., Pérez, T. B., Martinez, C. A. G., & Abreu-Lomba, A. (2023) · Interdisciplinary Journal of Epidemiology and Public Health · doi:10.18041/2665-427x/ijeph.1.10262
Análise metabolômica e histomorfométrica do fígado de ratas adultas em modelo experimental da síndrome dos ovários policísticos induzida por exposição neonatal a esteroides sexuais
Anzai, Á. (2015) · doi:10.11606/d.5.2015.tde-27102015-095105 · Cited by 1
Risco de Farmingham e evento cardiovascular em mulheres com síndrome dos ovários policísticos
Santos, A. G. (2014) · Americanae (AECID Library) · Cited by 1
Obesity and Reproduction
Ortiz-Flores, A. E., & Escobar-Morreale, H. F. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.66100-7 · Cited by 1
Self-citation
Skin Manifestations of Paediatric Metabolic Syndrome
Holzer, G., & Volc‐Platzer, B. (2019) · Harper's Textbook of Pediatric Dermatology · doi:10.1002/9781119142812.ch72 · Cited by 1
The potential diagnostic use of clinical characteristics and mitochondrial DNA copy numbers of peripheral blood and ovarian tissue in polycystic ovary syndrome (PCOS) patientPreprint
Song, Y., Deng, Y. P., Chung, J. P. W., Li, T. C., Wang, C. C., Li, H., Yang, T., Sui, Y., & Tang, T. (2021) · Research Square · doi:10.21203/rs.3.rs-1046361/v1 · Cited by 1
Laboratory Evaluation
Dumesic, D. A., & Al-Safi, Z. A. (2022) · doi:10.1093/med/9780198870197.003.0154 · Cited by 1
Self-citation
Current World Literature
(2010) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e328340e116 · Cited by 1
Single Nucleotide Polymorphism analysis of genes FTO, THADA, VEGFÇYP21, CYP11A1 in Polycystic Ovarian Syndrome in Pakistani PopulationPreprint
Bashir, K., Awan, N. R., Ahmad, M., Saif, S., & Aziz, Z. (2023) · Research Square · doi:10.21203/rs.3.rs-3301948/v1 · Cited by 1
Effect of non-esterified fatty acids on insulin resistance and cardiovascular risk in polycystic ovary syndrome
Aye, M. M. (2013) · Repository@Hull (Worktribe) (University of Hull) · Cited by 1
Diagnosis and Assessment
Stracquadanio, M., & Ciotta, L. (2015) · Springer eBooks · doi:10.1007/978-3-319-16760-2_5
Markers for Subclinical Atherosclerosis in Women with Polycystic Ovary Syndrome and Controls
Meyer, M. L. (2011) · D-Scholarship@Pitt (University of Pittsburgh)
Characterisation of microparticles and nitro-oxidative stress in cardiometabolic disease
Willis, G. R. (2015) · ORCA Online Research @Cardiff (Cardiff University)
Efectos del resveratrol en la fisiología ovárica y su potencial aplicación en el síndrome de ovario poliquístico
Sánchez, I. O. (2014) · BURJC Digital (King Juan Carlos University)
PCOS from Conception to Menopause: A Review of Our Current Understanding
Durrant, L. W. M., & Yaklic, J. L. (2015) · Andrology & Gynecology Current Research · doi:10.4172/2327-4360.1000133
Hiperandrogenismo y síndrome de ovario poliquístico
Escobar-Morreale, H. F., Buesa, M. A., Blasco, F. Á., & Luque‐Ramírez, M. (2012) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(12)70401-8
Self-citation
Cardiovascular risk in young women with Polycystic OvarySyndrome
Coulson, R.-M. K. (2014) · ORCA Online Research @Cardiff (Cardiff University)
High Risk, High Stakes: Optimizing Cardiovascular Risk Assessment in Women
Levit, R. D., & WENGER, N. K. (2012) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-012-0221-9
Infravaloración del riesgo cardiovascular en pacientes con ovario poliquístico
Vera, C. O., Pérez, M. R. C., Hernández, M. L., & Alemán, J. A. (2012) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2012.01.001
In search of the best combined oral contraceptive for treatment of polycystic ovary syndrome
Dokras, A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.07.1095
Self-citation
Polycystic Ovary Syndrome (PCOS): Making Sense of the Alphabet
Pal, L. (2011) · DOAJ (DOAJ: Directory of Open Access Journals)
Differential diagnoses of hyperandrogenism in a post menopausal woman
Dharshini, K., & Bulugahapitiya, U. (2014) · Sri Lanka Journal of Diabetes Endocrinology and Metabolism · doi:10.4038/sjdem.v3i2.6374
Clues to ovarian tumors: new concepts of symptoms, signs, syndromes, and paraneoplastic syndromes
Altchek, A., & Fishman, D. A. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003254.022
Umwelteinflüsse beim polyzystischen Ovarsyndrom
Tan, S., & Führer‐Sakel, D. (2015) · Gynäkologische Endokrinologie · doi:10.1007/s10304-015-0014-6
Transition clinics in women with polycystic ovary syndrome
Kalra, B., Baruah, M., & Gupta, Y. (2015) · Journal of Medical Nutrition and Nutraceuticals · doi:10.4103/2278-1870.162171
Guía de práctica clínica de síndrome de ovario
Castillo, D., Tirado, F. J. G., Ortega, M., Castro, A. J., Tirado, D. C., & Ana, R. (2014) · Dialnet (Universidad de la Rioja)
[Proteomics and PCOS: Is it here the missing link? Literature review].
Ruiz, I. O. C., de la Llata, E. S., Sánchez, M. R. M., Hernáez, M. L., Gutierrez‐Blazquez, M. D., & Sarrió, A. R. (2015) · PubMed
Cardiovascular Disease Prevention in Women
Russell, C. E., Rodríguez, F., & Foody, J. M. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_56
TBHEB 2016-1 Vol 73 Full Printed Journal
DUMAN, M. (2016) · Turkish Bulletin of Hygiene and Experimental Biology · doi:10.5505/turkhijyen.2016.02438
Adipose Tissue and Menstrual Disturbances: Obesity Versus Anorexia Nervosa
Vujović, S., Ivović, M., Tančić‐Gajić, M., Marina, L., Arizanović, Z., Barać, M., Ivanišević, M. F., Barac, B., Brkić, M., Djurović, M., et al. (2015) · ISGE series · doi:10.1007/978-3-319-23865-4_10
Thrombocytosis in Patients with Polycystic Ovary Syndrome
Saha, S. A. (2011) · Southern Medical Journal · doi:10.1097/smj.0b013e318214ac2a
Contraception for Women With PCOS: Benefit Versus Risk
Yıldız, B. O. (2013)
Polycystic Ovary Syndrome: Evaluation and Follow-up for Metabolic Disorders
Yıldız, B. O. (2014) · The Endocrine Society eBooks · doi:10.1210/mtp3.9781936704835.ch47
Psychotic disorders in women
(2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781107045132.022
History and physical examination of polycystic ovary syndrome: Detecting too much or too little
Kohorst, J. J., Fischer, A. S., & Rizk, C. B. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139649520.018
Disorders associated with insulin resistance
Duncan, A., & Barr, S. (2015) · Wiley eBooks · doi:10.1002/9781119121725.ch33
Treating women with schizophrenia
Smith, S. M., & Gaughran, F. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781107045132.024
Diagnose PCOS – was bedeutet das für die Betroffene?
Segerer, S. (2016) · Der Gynäkologe · doi:10.1007/s00129-016-3952-8
Role of Surgery in the Management of PCOS: Rationale and Considerations for Bariatric Surgery
Escobar-Morreale, H. F. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_16
Self-citation
Polycystic Ovary Syndrome: Implications for Cardiovascular, Endometrial, and Breast Disease
Escobar-Morreale, H. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95859-8
Self-citation
Asymptomatic Fibroids and Infertility
Rhoton-Vlasak, A. S., & Plasencia, E. (2017) · Springer eBooks · doi:10.1007/978-3-319-58780-6_12
PCOS: Implications of Cardiometabolic Dysfunction
Fauser, B. C. J. M. (2017) · ISGE series · doi:10.1007/978-3-319-63540-8_10
Definition criteria and diagnostic assessments
Orio, F., Volpe, A., Stasi, V. D., Savastano, S., Lombardi, G., & Colao, A. (2013) · doi:10.2217/ebo.12.194
Management of the metabolic syndrome and glucose intolerance in women with PCOS
Pasquali, R. (2013) · doi:10.2217/ebo.12.271
A new look at the polycystic ovary syndrome
Stefanowicz-Rutkowska, M. M., Myszka-Podgórska, K., Matuszewski, W., Baranowska, A., Modzelewski, R., & Bandurska-Stankiewicz, E. M. (2018) · Polish Annals of Medicine · doi:10.29089/2017.17.00049
Effect of android fat distribution on thrombin‐activatable fibrinolysis inhibitor levels in women with polycystic ovary syndrome
de Mendonça-Louzeiro, M. R. M. F., de Andrade, K. C., Yela, D. A., & Benetti‐Pinto, C. L. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12571
Dyslipidemia in Women with Polycystic Ovary Syndrome in Khammam District, Telangana, India
Priyanka, M., Bhaskar, M. V., Madhulatha, M., & Kodumuri, P. K. (2017) · International Journal of Advanced and Integrated Medical Sciences · doi:10.5005/jp-journals-10050-10102
THE EFFECTS OF TREATMENT WITH ORAL CONTRACEPTIVE PILL CONTAINING ETHINYL ESTRADIOL-CYPROTERONE ACETATE ALONE OR IN COMBINATION WITH METFORMIN ON CLINICAL, HORMONAL, METABOLIC AND ULTRASONOGRAPHIC CHARACTERISTICS IN POLYCYSTIC OVARIAN SYNDROME
Sahu, M., & Tripathy, P. (2018) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2018/485
Chronic Passive Heat Exposure and Cardiometabolic Health in Obese Women with Polycystic Ovary Syndrome
Ely, B. R. (2018) · Scholars' Bank (University of Oregon)
THE NUTRITIONAL PRACTICE, PERSONAL, HEALTHY AND HABITUAL RISK FACTORS RELATED TO CARDIOVASCULAR DISEASES OF FEMALE EMPLOYEES AND STUDENTS AT KING FAISAL UNIVERSITY, AL-AHASSA PROVINCE, KINGDOM OF SAUDI ARABIA
Alabbad, N. (2018) · Arab Universities Journal of Agricultural Sciences · doi:10.21608/ajs.2018.28252
Sex Differences in Coronary Artery Disease
Kawamoto, K. R., Duvernoy, C. S., & Davis, M. B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813197-8.00012-9
Lipidstoffwechsel in normgewichtigen PCOS-Patientinnen
Radan, A. (2019) · Journal für Gynäkologische Endokrinologie/Schweiz · doi:10.1007/s41975-019-0091-3
Salivary Interleukin-6 Levels among Polycystic Ovary Syndrome (Pcos) Patients with and Without Chronic Periodontitis - A Comparitive Study
Varghese, D. A., Christy, A. J., Pratheeba, B., Saraswathy, P., & Ravi, D. S. (2019) · International Journal of Innovative Research in Medical Science · doi:10.23958/ijirms/vol04-i09/742
Clinical Features and Assessment of Hyperandrogenism: Differential Diagnosis for Clinical Use
Stracquadanio, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-29223-2_3
Sindrome de ovarios poliquisticos y riesgo cardiovascular: lo establecido y desconocido de un problema reconocido
Rojas, J., Chávez-Castillo, M., Olivar, L. C., & Bermúdez, V. (2013) · Redalyc (Universidad Autónoma del Estado de México)
The Effects of Induced Polycystic Ovary Syndrome in NAG-1 Transgenic Mice
Werner, N. (2020) · ScholarWorks (Central Washington University)
Het polycystisch ovariumsyndroom: actuele richtlijnen voor diagnose in de eerste lijn en vruchtbaarheidsbehandeling
Hellebaut, S., Meerschaut, F. V., & Vandekerckhove, F. (2020) · Tijdschrift voor Geneeskunde · doi:10.47671/tvg.76.20.039
Postmenopausal Alopecia due to Ovarian Hyperandrogenemia Treated with Bilateral Salpingo-oophorectomy
Acharya, S., Chakravorty, S., & RAE, D. W. (2020) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-1771
Cardiovascular Risk in Reproductive-aged Women With Polycystic Ovary Syndrome According to Body Mass Index: a Systematic Review and Meta-analysisPreprint
Zhuang, C., Wang, Q., Wang, W.-J., Sun, R., Zhang, X., & Yu, J. (2021) · Research Square · doi:10.21203/rs.3.rs-230193/v1
Family-Based Analysis of -675 4G/5G Polymorphism in the PAI-1 Gene in Chinese Polycystic Ovary SyndromePreprint
Ge, L., Song, C. X., Wang, S. D., Li, L., Dong, M., & Song, C. X. (2021) · Research Square · doi:10.21203/rs.3.rs-382013/v1
Effect of Metformin Therapy on Clinical and Hormonal Indices of Patients with Polycystic Ovary Syndrome
Inayat, S., Khattak, H. F., Muhammad, M. G., Robeen, K., Inayat, A., & Fatima, F. (2021) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs211551522
Androgen excess in women
Lobo, R. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-65399-2.00047-4
Self-citation
Effect of Exercise Interventions on Metabolic, Reproductive and Mental Health in Overweight Women with Polycystic Ovary Syndrome
Patten, R. K. (2021) · Victoria University Research Repository (Victoria University)
The Comparative Effect of Citrullus colocynthis Hydro-Alcoholic Extract and Metformin on Morphometric Ovarian Follicles Disorders in Estradilol Valerate Iinduced-Polycystic Ovary Syndrome Rats.
Bafrouei, M. H. B., Khazali, H., Kalantar, S. M., & Khoradmehr, A. (2018) · PubMed Central · doi:10.22086/gmj.v0i0.1045
Evaluation of Cardiovascular Disease Risk in Women having Poly Cystic Ovarian Syndrome
Rao, G. (2021) · Journal of Cardiology and Cardiovascular Research · doi:10.37191/mapsci-jccr-2(3)-036
Evaluación de parámetros endócrino metabólicos en los nuevos fenotipos diagnósticos de pacientes con síndrome de ovario poliquístico
Otta, C. F. (2012)
Polycystic Ovary Syndrome and Inflammation
Chedraui, P. A., & Pérez-López, F. R. (2021) · ISGE series · doi:10.1007/978-3-030-63650-0_15
Hyperandrogenism
Lobo, R. A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-323-06986-1.00040-8
Self-citation
Polycystic Ovary Syndrome
Ehrmann, D. A., & Sam, S. (2022) · doi:10.1093/med/9780198870197.003.0160
Current World Literature
(2011) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e3283491e27
Cardiovascular Disease Prevention in Women
Russell, C. E., Rodríguez, F., & Foody, J. M. (2014) · Springer eBooks · doi:10.1007/978-3-642-37393-0_56-1
Treatments
Stracquadanio, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-29223-2_4
Serum Fetuin-A levels were increased and associated with insulin resistance in women with polycystic ovary syndromePreprint
Liu, S., Hu, W., He, Y., Li, L., Liu, H., Gao, L., Yang, G., & Liao, X. (2019) · doi:10.21203/rs.2.16806/v1

Authors: Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A.
Affiliations: OU Health (US)
University of Palermo (IT)
University of Athens Medical School (E.D.-K.), 11527 Athens, Greece
University of Pennsylvania (US)
Hospital Ramon y Cajal (H.F.E.-M.), 28034 Madrid, Spain
Icahn School of Medicine at Mount Sinai (US)
Columbia University (R.L.), New York, New York 10027
The University of Adelaide (AU)
University of Pittsburgh (US)
University of Wisconsin–Madison (US)
Corresponding author: Carmina, Enrico
ORCID: Wild, Robert A.
Carmina, Enrico
Dokras, Anuja
Norman, Robert J.
Talbott, Evelyn
Dumesic, Daniel A.
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 2010-05-01
Volume: 95
Issue: 5
Pages: 2038-2049
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jc.2009-2724
OpenAlex: W2105749473
Semantic Scholar: 5556ce96457d5a9ef1f00894a9f61047e5c6afb4
Cited by: 1,010
References: 146
Citations by year: 2026: 34 · 2025: 47 · 2024: 45 · 2023: 62 · 2022: 77 · 2021: 52 · 2020: 56 · 2019: 73 · 2018: 61 · 2017: 58 · 2016: 62 · 2015: 89 · 2014: 85 · 2013: 69 · 2012: 62
FWCI: 79.63
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: polycystic ovary syndrome, cardiovascular risk, cardiovascular disease prevention, hyperandrogenism, obesity, dyslipidemia, hypertension, impaired glucose tolerance, metabolic syndrome, type 2 diabetes, subclinical vascular disease, body mass index, waist circumference, oral glucose tolerance test, mood disorders, lifestyle management, insulin-sensitizing drugs, cardiovascular risk assessment
MeSH terms: Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Polycystic Ovary Syndrome, Risk Factors, Body Mass Index, Glucose Intolerance, Risk Assessment, Waist-Hip Ratio, Atherosclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks